Treating and preventing motor neuron diseases using nicotinamide riboside
US11730751B2 · kind B2 · utility
0Cited by
0References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 16, 2018 |
| Grant date | Aug 22, 2023 |
| Priority date | — |
| Expiry date | Jun 10, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods and compositions related to treating motor neuron diseases, such as ALS, in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.